Dr. R.E. de Bruijn - Ziekenhuis Amstelland

HomeMaak kennis met onze specialistenDr. R.E. de Bruijn

De heer de Bruijn is sinds 2018 als uroloog werkzaam in Ziekenhuis Amstelland.

BIG Registratie: 79913169401

Aandachtsgebied

Oncologische urologie
Goedaardige prostaatvergroting
Niersteenlijden

Werkervaring

Fellow oncologische urologie, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam
AIOS urologie, Amsterdam Universitair Medisch Centrum
AIOS urologie, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam
AIOS urologie, Onze Lieve Vrouwen Gasthuis, Amsterdam
AIOS chirurgie (vooropleiding), Westfries Gasthuis, Hoorn
ANIOS urologie, Medisch Centrum Haaglanden, Den Haag
ANIOS heelkundige oncologische disciplines, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam

Opleiding

Opleiding urologie, Cluster Amsterdam
Studie Geneeskunde, Universiteit van Amsterdam

Promotieonderzoek
Oktober 2020: Management and prognosis assessment in advanced renal cell carcinoma

Aanwezig
Dinsdag t/m vrijdag.

Publicaties

Deferred cytoreductive nephrectomy following presurgical VEGFR-targeted therapy in patients with primary metastatic clear-cell renal cell carcinoma: A pooled analysis of prospective trial data.
De Bruijn RE, Wimalasingham A, Stewart G, Blank C, Haanen JB, Klatte T, Staehler M, Powles T, Bex A
Eur Urol Oncol. 2020 Jan 16. pii: S2588-9311(20)30001-8
Surgical safety of cytoreductive nephrectomy following sunitinib: Results from the multi-centre randomized controlled trial of immediate versus deferred nephrectomy (SURTIME).
De Bruijn RE, Mulders P, Jewett M, Wagstaff J, Van Thienen JV, Blank CU, Van Velthoven R, Wood L, Van Melick HE, Aarts MJ, Lattouf JB, Powles T, De Jong IJ, Rottey S, Tombal B, Marreaud S, Collette S, Haanen JB, Bex A.
Eur Urol. 2019 Oct;76(4):437-440
Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.
Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BW, Wit EM, Bex A.
Scand J Urol. 2018 Oct – Dec;52(5-6):411-418
An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors.
Kuusk T, Donswijk ML, Valdés Olmos RA, De Bruijn RE,Brouwer OR, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A.
EJNMMI Res. 2018 Dec 3;8(1):105
External validation of a prediction model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Marconi L, de Bruijn RE, Van Werkhoven E, Beisland B, Heidenreich A Karam J, Kauffmann C, Klatte T,Ljungberg B, Staehler M, Stewart G, Uzzo R, Wood L, Wood C, Bex A.
World J Urol. 2018 Dec;36(12):1973-1980
Lymphatic drainage from renal tumors in vivo: a prospective sentinel node study using SPECT/CT imaging.
Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Grivas N, Hendricksen K, Horenblas S, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A.

Author Reply: Observation after cytoreductive nephrectomy in patients with synchronous not completely resected metastases of renal cell carcinoma
De Bruijn RE, Bex A.
Urology. 2017 Nov;109:132-133
Observation after cytoreductive nephrectomy in patients with synchronous not completely resected metastases of renal cell carcinoma.
De Bruijn RE, Kuusk T, Noe A, Blank C, Haanen JB, Horenblas S, Bex A.
Urology 2017 Nov; 109:127-133
The current management of renal cell carcinoma.
Kuusk T, Grivas N, De Bruijn R, Bex A.
Minerva Med. 2017 Aug;108(4):357-369
Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy.
Noe A, de BruijnRE, BlankCU, HorenblasS, HaanenJB and BexA. World J Urol. 2016 Aug;34(8):1067-72
Baseline tumor volume in assessing prognosis of patients with intermediate-risk synchronous metastatic renal cell carcinoma. De Bruijn RE, Nijkamp J, Noe A, Horenblas S, Haanen JB, Prevoo, W, Bex A.
Urol Oncol. 2016 Jun;34(6):258.e7-258.e13. Letter to the Editor: Timing of cholecystectomy in acute cholecystitis. De Bruijn RE, Van IJsseldijk A and Sonneveld DJA
Ann Surg. 2015 Aug;262(2):e87
Case report. Urethroscopiegeassisteerde percutane lithotomie bij hypospadie. De Bruijn RE, Groenendijk PM, Berger CPAM and Leenarts JAF
Tijdschrift voor Urologie 2013: 3(8)
Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation.